These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36694313)

  • 1. Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer.
    Nandi S; Chauhan B; Tarannum H; Khede MK
    Curr Top Med Chem; 2023; 23(5):403-414. PubMed ID: 36694313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach.
    Madugula SS; Nagamani S; Jamir E; Priyadarsinee L; Sastry GN
    Mol Divers; 2022 Jun; 26(3):1675-1695. PubMed ID: 34468898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
    Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
    Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacology - foe or friend?
    Peters JU
    J Med Chem; 2013 Nov; 56(22):8955-71. PubMed ID: 23919353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
    Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
    Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AI for targeted polypharmacology: The next frontier in drug discovery.
    Cichońska A; Ravikumar B; Rahman R
    Curr Opin Struct Biol; 2024 Feb; 84():102771. PubMed ID: 38215530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Polypharmacological Profiles by Affinity Fingerprinting.
    Peragovics A; Simon Z; Malnasi-Csizmadia A; Bender A
    Curr Pharm Des; 2016; 22(46):6885-6894. PubMed ID: 27587199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
    Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacology: The science of multi-targeting molecules.
    Kabir A; Muth A
    Pharmacol Res; 2022 Feb; 176():106055. PubMed ID: 34990865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis.
    Stelitano G; Sammartino JC; Chiarelli LR
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32182964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
    Chopra G; Samudrala R
    Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacology in Precision Oncology: Current Applications and Future Prospects.
    Antolin AA; Workman P; Mestres J; Al-Lazikani B
    Curr Pharm Des; 2016; 22(46):6935-6945. PubMed ID: 27669965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-target-based polypharmacology prediction (mTPP): An approach using virtual screening and machine learning for multi-target drug discovery.
    Liu K; Chen X; Ren Y; Liu C; Lv T; Liu Y; Zhang Y
    Chem Biol Interact; 2022 Dec; 368():110239. PubMed ID: 36309139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.
    Ma X; Lv X; Zhang J
    Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking Studies for Multi-Target Drugs.
    Scotti L; Mendonca Junior FJ; Ishiki HM; Ribeiro FF; Singla RK; Barbosa Filho JM; Da Silva MS; Scotti MT
    Curr Drug Targets; 2017; 18(5):592-604. PubMed ID: 26302806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.